Many cases of GAD65 autoimmune encephalitis are described in adults, but this is an understudied topic in children. Not many pediatric cases of GAD65 encephalitis are reported in literature and the diagnostic criteria are not well defined. This is a retrospective observational study of 3 pediatric patients with GAD65 antibodies seen at Arkansas Children's Hospital between 2016 and 2022. GAD65 antibody is a biomarker of autoimmune central nervous system disorder and more commonly non-neurologic disorders like type 1 diabetes mellitus, autoimmune thyroid diseases and pernicious anemia. This case series illustrates the spectrum of symptoms associated with GAD65 in a pediatric population.
CellucciTVan MaterHGrausF, et al.Clinical approach to the diagnosis of autoimmune encephalitis in the pediatric patient. Neurol Neuroimmunol Neuroinflam. 2020;7(2):e663.
4.
YogeswaraIBAManeeratSHaltrichD. Glutamate decarboxylase from lactic acid bacteria—a key enzyme in GABA synthesis. Microorganisms. 2020;8(12):1923. doi:10.3390/microorganisms8121923
5.
DadeMBerzeroGIzquierdoC, et al.Neurological syndromes associated with anti-GAD antibodies. Int J Mol Sci.2020;21(10):3701. doi:10.3390/ijms21103701
6.
DkhissiOJulienJFWasowiczM, et al.Differential expression of GAD(65) and GAD(67) during the development of the rat retina. Brain Res. 2001;919(2):242-249. doi:10.1016/S0006-8993(01)03022-0
7.
TownsRPietropaoloM. GAD-65 autoantibodies and their role as biomarkers of type 1diabetes and latent autoimmune diabetes in adults (LADA). Drugs Future.2011;36(11):847. doi:10.1358/dof.2011.36.11.1710754
8.
JinPHuangGLinJ, et al.Epitope analysis of GAD65 autoantibodies in adult-onset type 1 diabetes and latent autoimmune diabetes in adults with thyroid autoimmunity. Acta Diabetol. 2011;48(2):149-155. doi:10.1007/s00592-010-0250-0
9.
MantoMULauteMAAgueraM, et al.Effects of anti-glutamic acid decarboxylase antibodies associated with neurological diseases. Ann Neurol. 2007;61(6):544-551. doi:10.1002/ana.21123
10.
MitomaHMantoMHampeCS. Pathogenic roles of glutamic acid decarboxylase 65 autoantibodies in cerebellar ataxias. J Immunol Res.2017;2017:2913297. doi:10.1155/2017/2913297
11.
LiXGuoQZhengZ, et al.Immune-mediated epilepsy with GAD65 antibodies. J Neuroimmunol.2020;341:577189. doi:10.1016/j.jneuroim.2020.577189
12.
GagnonMSavardM. Limbic encephalitis associated with GAD65 antibodies: brief review of the relevant literature. Can J Neurol Sci.2016;43(4):486-493. doi:10.1017/cjn.2016.13
13.
KammeyerRPiquetAL. Multiple co-existing antibodies in autoimmune encephalitis: a case and review of the literature. J Neuroimmunol. 2019;337:577084. doi:10.1016/j.jneuroim.2019.577084
14.
Baizabal-CarvalloJF. The neurological syndromes associated with glutamic acid decarboxylase antibodies. J Autoimmun. 2019;101:35-47. doi:10.1016/j.jaut.2019.04.007
15.
FredriksenJRCarrCMKoellerKK, et al.MRI findings in glutamic acid decarboxylase associated autoimmune epilepsy. Neuroradiology. 2018;60(3):239-245. doi:10.1007/s00234-018-1976-6
16.
Conde-BlancoEPascual-DiazSCarreñoM, et al.Volumetric and shape analysis of the hippocampus in temporal lobe epilepsy with GAD65 antibodies compared with non-immune epilepsy. Sci Rep. 2021;11(1):10199. doi:10.1038/s41598-021-89010-z
17.
HarmonAStinglCRikhiA, et al.Pediatric GAD-65 autoimmune encephalitis: assessing clinical characteristics and response to therapy with a novel assessment scale. Pediatr Neurol. 2022;128:25-32. doi:10.1016/j.pediatrneurol.2021.12.007
VeriKUiboOTalvikT, et al.Newly-diagnosed pediatric epilepsy is associated with elevated autoantibodies to glutamic acid decarboxylase but not cardiolipin. Epilepsy Res. 2013;105(1-2):86-91. doi:10.1016/j.eplepsyres.2013.02.009
20.
TekturkPBaykanBErdagE, et al.Investigation of neuronal auto-antibodies in children diagnosed with epileptic encephalopathy of unknown cause. Brain Dev. 2018;40(10):909-917. doi:10.1016/j.braindev.2018.06.002
21.
FalipMRodriguez-BelLCastañerS, et al.Musicogenic reflex seizures in epilepsy with glutamic acid decarboxylase antibodies. Acta Neurol Scand. 2018;137(2):272-276. doi:10.1111/ane.12799
22.
ClardySLLennonVADalmauJ, et al.Childhood onset of stiff-man syndrome. JAMA Neurol. 2013;70(12):1531-1536. doi:10.1001/jamaneurol.2013.4442
23.
AriñoHGresa-ArribasNBlancoY, et al.Cerebellar ataxia and glutamic acid decarboxylase antibodies. JAMA Neurol. 2014;71(8):1009-1016. doi:10.1001/jamaneurol.2014.1011
24.
ChanKSweatMZimbricMRNewfieldRS. 911-P: New-onset diabetes and cerebellar ataxia in a child: What does GAD-65 have to do with it?Diabetes. 2021;70(Supplement_1):911-P. doi:10.2337/db21-911-P
25.
FauserSUttnerIAriñoH, et al.Long latency between GAD-antibody detection and development of limbic encephalitis--a case report. BMC Neurol. 2015;15:177. doi:10.1186/s12883-015-0435-9
26.
LinJJLinKLHsiaSH, et al.Antiglutamic acid decarboxylase antibodies in children with encephalitis and status epilepticus. Pediatr Neurol. 2012;47(4):252-258. doi:10.1016/j.pediatrneurol.2012.06.013
27.
ChaudhuriJMukherjeeAChakravartyA. Hashimoto's encephalopathy: case series and literature review. Curr Neurol Neurosci Rep. 2023;23(4):167-175. doi:10.1007/s11910-023-01255-5
28.
BudhramASechiEFlanaganEP, et al.Clinical spectrum of high-titre GAD65 antibodies. J Neurol Neurosurg Psychiatry. 2021;92(6):645-654. doi:10.1136/jnnp-2020-325275
29.
OlbergHKEideGEVedelerCA. Can serum GAD65 antibody levels predict neurological disease or cancer?J Neuroimmunol. 2019;336:577025. doi:10.1016/j.jneuroim.2019.577025
30.
AriñoHHöftbergerRGresa-ArribasN, et al.Paraneoplastic neurological syndromes and glutamic acid decarboxylase antibodies. JAMA Neurol. 2015;72(8):874-881. doi:10.1001/jamaneurol.2015.0749
31.
TröscherARMairKMVerdú de JuanL, et al.Temporal lobe epilepsy with GAD antibodies: neurons killed by T cells not by complement membrane attack complex. Brain. 2023;146(4):1436-1452. doi:10.1093/brain/awac404
32.
HaberlandtEBastTEbnerA, et al.Limbic encephalitis in children and adolescents. Arch Dis Child. 2011;96(2):186-191. doi:10.1136/adc.2010.183897
